|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sudhan DR and Siemann DW: Cathepsin L
inhibition by the small molecule KGP94 suppresses tumor
microenvironment enhanced metastasis associated cell functions of
prostate and breast cancer cells. Clin Exp Metastasis. 30:891–902.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qiu X and Dou Y: miR-1307 promotes the
proliferation of prostate cancer by targeting FOXO3A. Biomed
Pharmacother. 88:430–435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang Z, Xu L, Hu Y, Huang Y, Zhang Y,
Zheng X, Wang S, Wang Y, Yu Y, Zhang M, et al: miRNA let-7b
modulates macrophage polarization and enhances tumor-associated
macrophages to promote angiogenesis and mobility in prostate
cancer. Sci Rep. 6:256022016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen QG, Zhou W, Han T, Du SQ, Li ZH,
Zhang Z, Shan GY and Kong CZ: MiR-345 suppresses proliferation,
migration and invasion by targeting Smad1 in human prostate cancer.
J Cancer Res Clin Oncol. 142:213–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu J, Ji A, Wang X, Zhu Y, Yu Y, Lin Y,
Liu Y, Li S, Liang Z, Xu X, et al: MicroRNA-195-5p, a new regulator
of Fra-1, suppresses the migration and invasion of prostate cancer
cells. J Transl Med. 13:2892015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tan G, Wu L, Tan J, Zhang B, Tai WC, Xiong
S, Chen W, Yang J and Li H: MiR-1180 promotes apoptotic resistance
to human hepatocellular carcinoma via activation of NF-κB signaling
pathway. Sci Rep. 6:223282016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou X, Zhu HQ, Ma CQ, Li HG, Liu FF,
Chang H and Lu J: MiR-1180 promoted the proliferation of
hepatocellular carcinoma cells by repressing TNIP2 expression.
Biomed Pharmacother. 79:315–320. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen EG, Zhang JS, Xu S, Zhu XJ and Hu HH:
Long non-coding RNA DGCR5 is involved in the regulation of
proliferation, migration and invasion of lung cancer by targeting
miR-1180. Am J Cancer Res. 7:1463–1475. 2017.PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Josson S, Chung LW and Gururajan M:
microRNAs and prostate cancer. Adv Exp Med Biol. 889:105–118. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Swaffer MP, Jones AW, Flynn HR, Snijders
AP and Nurse P: CDK substrate phosphorylation and ordering the cell
cycle. Cell. 167:1750–1761.e16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Georgakilas AG, Martin OA and Bonner WM:
p21: A two-faced genome guardian. Trends Mol Med. 23:310–319. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sherr CJ: The Pezcoller lecture: Cancer
cell cycles revisited. Cancer Res. 60:3689–3695. 2000.PubMed/NCBI
|
|
16
|
Han S, Woo JK, Jung Y, Jeong D, Kang M,
Yoo YJ, Lee H, Oh SH, Ryu JH and Kim WY: Evodiamine selectively
targets cancer stem-like cells through the p53-p21-Rb pathway.
Biochem Biophys Res Commun. 469:1153–1158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morales-Cano D, Calvino E, Rubio V,
Herráez A, Sancho P, Tejedor MC and Diez JC: Apoptosis induced by
paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4
human leukaemia cells is not modulated by ERK inhibition. Exp
Toxicol Pathol. 65:1101–1108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu L, Li L, Medeiros LJ and Young KH:
NF-κB signaling pathway and its potential as a target for therapy
in lymphoid neoplasms. Blood Rev. 31:77–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kramer N, Walzl A, Unger C, Rosner M,
Krupitza G, Hengstschläger M and Dolznig H: In vitro cell migration
and invasion assays. Mutat Res. 752:10–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choudhary S, Kalita M, Fang L, Patel KV,
Tian B, Zhao Y, Edeh CB and Brasier AR: Inducible tumor necrosis
factor (TNF) receptor-associated factor-1 expression couples the
canonical to the non-canonical NF-κB pathway in TNF stimulation. J
Biol Chem. 288:14612–14623. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yue X, Zhao Y, Liu J, Zhang C, Yu H, Wang
J, Zheng T, Liu L, Li J, Feng Z and Hu W: BAG2 promotes
tumorigenesis through enhancing mutant p53 protein levels and
function. Elife. 4:2015. View Article : Google Scholar
|
|
22
|
Zhang J, Lou X, Yang S, He S, Yang L, Liu
M, Zhu H, Shan Q, Su S, Zhan Q, et al: BAG2 is a target of the
c-Myc gene and is involved in cellular senescence via the p21(CIP1)
pathway. Cancer Lett. 318:34–41. 2012. View Article : Google Scholar : PubMed/NCBI
|
